MedTrace Logo

Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital

NCT02868606 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40391

Last updated 2019-06-04

No results posted yet for this study

Summary

Many hospitals have begun giving insulin to nearly all patients with diabetes while they are in the hospital even if a patient does not use insulin at home. Controlling blood sugar with insulin when a patient is hospitalized is believed to reduce the risk of complications and death, but research has not demonstrated these benefits except in patients who are critically ill. The purpose of this study, therefore, is to evaluate whether such insulin therapy actually does reduce in-hospital complications, deaths, need for intensive care, or length of stay in the hospital.

Conditions

Interventions

OTHER

Physiologic Insulin Therapy

OTHER

Sliding-Scale Insulin Therapy

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Winthrop University Hospital

    lead OTHER

Principal Investigators

  • Donald A Brand, Ph.D. · Winthrop University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-08-15
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02868606 on ClinicalTrials.gov